Why Were Definitive Drug Testing LCDs Retired in Clinical Diagnostics?

Drug testing is a vital component of clinical diagnostics, allowing healthcare professionals to detect the presence of drugs in a patient’s system and make informed decisions about their treatment. In recent years, there has been a shift away from definitive drug testing LCDs (liquid chromatography-mass spectrometry) in favor of newer technologies. In this blog post,…

Read More

The Decision to Retire Definitive Drug Testing LCDs in Clinical Diagnostics: A Closer Look

In the field of clinical diagnostic labs, decisions to retire certain testing methods or assays are not made lightly. There are a multitude of factors that come into play during the decision-making process, including regulatory requirements, technological advancements, cost considerations, and clinical utility. In this blog post, we will explore the decision to retire the…

Read More

The Department Of Health And Human Services’ Responsibilities In Regard To The Covid Testing Pay Ratio

As the COVID-19 pandemic continues to impact communities around the world, testing for the virus has become a crucial part of the strategy to control its spread. The Department of Health and Human Services (HHS) plays a key role in overseeing healthcare policies and programs in the United States, including COVID testing initiatives. In this…

Read More